When tumor involvement of the frontal sinus occurs, it is usually the result of the direct spread of the mass from the nasal cavity or anterior ethmoid sinuses. Primary frontal sinus tumors are extremely rare. We describe a case of primary adenocarcinoma of the frontal sinus in a 53-year-old man. Th e patient refused surgery, so he was treated with chemotherapy followed by radiotherapy. At the 1-year follow-up, only a slight reduction of the swelling was noted. Th ereaft er, he was lost to follow-up. Th is case represents a typical example of a paranasal cancer extending beyond the bony margins, with a silent onset that simulated benign disease. Th e best hope for an early diagnosis of such a tumor lies in the greater use of computed tomography to assess chronic rhinosinusitis.
Introduction
Paranasal neoplasms involving the nasal cavity or sinuses account for less than 1% of all carcinomas and approximately 3% of those occurring in the upper aerodigestive tract. 1 Generally, the incidence in men is twice that of women. 2 Th ese tumors are most oft en found during the fi ft h through seventh decades of life.
Th e risk of a paranasal malignancy is higher in patients who have been exposed to wood dust, nickel dust, isopropyl oil, chromium, dichlorodiethyl sulfi de, mustard gas, and the radiologic contrast agent Th orotrast. Some of these products have been used in the furniture industry, leather industry, and textile industry. Cigarette smoking and environmental pollution also increase the risk of developing a sinonasal carcinoma. 3 In most series, squamous cell carcinoma has been the most common histologic type, with an incidence of roughly 80%; adenoid cystic carcinomas and adenocarcinomas are next in frequency (~10% each). 4 Numerous other tumors complete the list in small numbers. Th e maxillary sinus is the primary site in roughly 60% of patients, the nasal cavity in 30%, and the ethmoid sinuses in 10%. 1 Primary tumors of the frontal and sphenoid sinuses are very rare.
In Denmark, Grau et al analyzed fi ve retrospective series that included a total of 315 patients who had been seen over a 10-year period, and they found only 1 case of a frontal sinus cancer. 5 When the frontal sinus is involved, it is usually as the result of a direct spread of tumor from the nasal cavity or anterior ethmoid sinuses. Metastasis to the sinuses is rare; when it does occur, the most common sites of origin are the kidney, breast, pulmonary system, and gastrointestinal tract.
In this article, we describe a new case of primary adenocarcinoma of the frontal sinus.
Case report
A 53-year-old man was admitted with a 3-month history of a slowly progressive swelling over the left side of his forehead and left upper eyelid. Th e swelling was associated with decreased vision in the left eye and a unilateral nasal discharge. He also complained of headache over the preceding 8 months and 2 episodes of nosebleed. He had no history of nasal obstruction, and he denied tobacco abuse or contact with chemicals and wood dust. He had received broad-spectrum antibiotics in the past.
Physical examination revealed that the swelling was tender. A palpable defect was felt over the fl oor of the frontal sinus, and the left eye was displaced forward and downward. Findings on nasal endoscopy were unremarkable. Computed tomography (CT) demonstrated an the overall and disease-free survival rates at 5 years were 53%. 7 Th e results of endoscopic resection of malignant tumors of the nasal cavity and paranasal sinuses have been encouraging. By its nature, surgical resection is performed in a piecemeal fashion, with frozen-section control. In a series of 49 patients with a variety of cancers, Lund et al performed endoscopic sinus surgery in combination with pre-or postoperative radio-and chemotherapy; they reported an overall 5-year survival rate of 88%. 8 Patients who are a poor surgical risk and those who refuse surgery should be treated with chemotherapy followed by radiotherapy.
Had our patient agreed to surgery, a craniofacial frontoethmoidectomy would have been necessary, followed by radiotherapy. Postoperative radiation oft en controls microscopically positive resection margins.
Our case represents a typical example of a paranasal cancer extending beyond the bony margins, with a silent enhancing soft -tissue mass that involved the left frontal sinus (fi gure 1). Th e mass had destroyed the posterior table and orbital roof, leading to orbital involvement.
Aft er providing informed consent, the patient agreed to undergo an open biopsy. Th e specimen was obtained through an incision made below the eyebrow. Histologic examination revealed it to be an adenocarcinoma (fi gure 2). Findings on a subsequent metastatic evaluation were negative. Th e patient refused surgery, so he was treated with chemotherapy followed by radiotherapy. At 1 year of follow-up, only a slight reduction of the swelling was noted. Improvement was noted in all other symptoms except the vision disturbance. Th ereaft er, the patient was lost to follow-up.
Discussion
Despite the anatomic proximity of the ethmoid and frontal sinuses, adenocarcinomas are common in the former site and rare in the latter. Contrast-enhanced CT and magnetic resonance imaging (MRI) provide an excellent delineation of tumor extent. 6 CT is excellent for demonstrating opacifi cation, mass eff ect, and bone destruction. In general, malignancies erode bone, whereas benign processes cause a reactive thickening or remodeling of adjacent bone. MRI is excellent for delineating soft -tissue lesions and important adjacent structures such as the orbit and anterior fossa. With T1and T2-weighted imaging and gadolinium enhancement, MRI can identify the true extent of a tumor.
Another particular benefi t of MRI is its ability to differentiate tissue densities and thereby ascertain with near-perfect accuracy the diff erence between tumor bulk and retained secretions in the sinuses. Our patient refused surgery, so we did not obtain MRI.
Because frontal sinus tumors are so rare, no universally accepted staging system has been developed. Many centers use the staging system that was originally promulgated by the University of Florida for ethmoid, sphenoid, and frontal sinus tumors and which is now applied to the entire paranasal area. 6 According to this system, stage 1 tumors are limited to the site of origin, stage 2 tumors extend only to immediately adjacent sites (except in cases of intracranial invasion), and stage 3 tumors exhibit intracranial erosion. 6 Defi nitive treatment has included surgery, radiotherapy, and chemotherapy in diff erent combinations. Multimodality therapy is widely advocated regardless of the order of treatment. Samant et al studied the use of high-dose intra-arterial cisplatin with concomitant irradiation of the paranasal sinuses and found that both onset that simulated benign disease. Th e best hope for an early diagnosis in such cases lies in the greater use of CT for the assessment of chronic rhinosinusitis. 1 If a nonhypertensive elderly patient is treated for epistaxis, CT should be obtained aft er the nasal pack has been removed.
